General Information of Disease (ID: DISV4PM2)

Disease Name Esophageal candidiasis
Synonyms esophageal thrush; esophageal moniliasis; candidiasis of the oesophagus; candidiasis of the esophagus; candidal esophagitis; Candida esophagitis
Definition Esophagitis resulting from Candida.
Disease Hierarchy
DISOOKGO: Fungal esophagitis
DISIRYMU: Candidiasis
DISV4PM2: Esophageal candidiasis
Disease Identifiers
MONDO ID
MONDO_0001648
UMLS CUI
C0239295
MedGen ID
66784
HPO ID
HP:0033351
SNOMED CT ID
20639004

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 7 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Amphotericin B DMTAJQE Approved Small molecular drug [1]
Anidulafungin DM8QM5U Approved Small molecular drug [2]
Caspofungin DMGQIPT Approved Small molecular drug [3]
Fluconazole DMOWZ6B Approved Small molecular drug [4]
Itraconazole DMCR1MV Approved Small molecular drug [5]
Micafungin DM6Y3AN Approved Small molecular drug [6]
Voriconazole DMAOL2S Approved Small molecular drug [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 1 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
DEFB4A TTIVY12 Strong Altered Expression [8]
------------------------------------------------------------------------------------
This Disease Is Related to 2 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ADGRV1 OTLVXHHP Strong Genetic Variation [9]
DEFB103B OT8RWY64 Strong Altered Expression [8]
------------------------------------------------------------------------------------

References

1 Amphotericin B FDA Label
2 Anidulafungin FDA Label
3 Caspofungin FDA Label
4 Fluconazole FDA Label
5 Itraconazole FDA Label
6 Micafungin FDA Label
7 Voriconazole FDA Label
8 IL-1 and ADAM17 are central regulators of -defensin expression in Candida esophagitis.Am J Physiol Gastrointest Liver Physiol. 2011 Apr;300(4):G547-53. doi: 10.1152/ajpgi.00251.2010. Epub 2011 Jan 13.
9 What is the clinical significance of esophagogastric junction outflow obstruction? evaluation of 60 patients at a tertiary referral center.Neurogastroenterol Motil. 2017 Jun;29(6). doi: 10.1111/nmo.13061. Epub 2017 Apr 9.